Key Comments Regarding OmniPlus Lawsuit: compounding pharmacy business models almost exclusively use non-FDA approved chemicals as starting materials rather than mixing one or more FDA-approved ingredients

Well and there it is, just like the saleswoman said, in #18--maybe the lawyers believed the marketing claim too. "Compounded done by OmniPlus consists of mixing one or more FDA-approved ingredients at the direction of the physician to meet the individual patient's specific needs" on More information on Dan Milosvic Remove content | Delete | Spam

I note that #16 in the complaint reads "Compounding pharmacies have the ability to mix multiple FDA-approved drugs or active ingredients to create a medication specifically tailored to a patient's needs." The language is misleading. Compounding pharmacy business models almost exclusively use non-FDA approved chemicals as starting materials, with the entire industry supported and facilitated by suppliers to the U.S. market, pharmacies do this to reap exceptionally large profit margins by dropping the bottom out of acquisition costs. This may be where some of the payer confusion arises from. At a medical meeting several years ago, a compounded drug saleswoman stated that although the drug she was promoting was not FDA approved, the individual ingredients contained in the drug were approved by FDA. That statement is false--FDA only approves product s in their finished dosage forms, with packaging and labeling for safe use. Maybe payers were marketed to also, and believed the on More information on Dan Milosvic Remove content | Delete | Spam